Legend Biotech Operating Metrics

Period Ending	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023
Carvykti Net Trade Sales	1.67B	1.43B	1.18B	962.00M	787.00M	654.00M	584.00M	500.00M
Carvykti Net Trade Sales Growth	111.69%	118.20%	101.20%	92.40%	98.74%	118.73%	183.50%	-

Revenue by Segment

Period Ending	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Collaboration	835.18M	716.18M	589.71M	482.58M	394.00M	327.11M	292.01M	249.80M				-
Collaboration Growth	111.98%	118.94%	101.95%	93.18%	99.18%	119.28%	183.62%	-				-
License	73.45M	80.06M	135.57M	138.40M	140.18M	138.20M	97.35M	-	-	-	-	-
License Growth	-47.60%	-42.07%	39.26%	-	-	-	-	-	-	-	-	-
Other	335.00K	598.00K	3.02M	6.26M	6.06M	5.80M	3.44M	167.00K
Other Growth	-94.47%	-89.69%	-12.27%	3,646.71%	1,736.97%	1,454.96%	900.00%	-49.09%

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.